
Crystalline forms of (S)-2-ethyl-7-fluoro-3-oxo-3,4-dihydro-2H-quinoxaline-1-carboxylic acid isopropyl ester, also known as (S)-1-methylethyl 2-ethyl-7-fluoro-3,4-dihydro-3-oxo-1(2H)-quinoxaline carboxylate, the compound of formula (I), process for their preparation, pharmaceutical formulations thereof and their use in therapy.
IPC: A61P31/12, IPC: C07D241/44, IPC: A61K31/495
IPC: A61P31/12, IPC: C07D241/44, IPC: A61K31/495
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
